NIKKEI 225
27,131.34 -457.06 (-1.66%) HANG SENG
24,243.61 -412.89 (-1.67%) CRUDE OIL
85.15 +1.84 (+2.21%) GOLD FUTURES
1,848.70 +7.00 (+0.38%) DOW
34,297.73 -66.77 (-0.19%) BTC-GBP
27,187.07 -328.85 (-1.20%)
Valneva SE American Depositary Shares (VALN)
- Globe Newswire
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
Saint-Herblain (France), January 25, 2022 – Valneva SE, a specialty vaccine company, today announced the start of booster vaccinations in adult participants from its Phase 3 pivotal trial, Cov-Compare. This booster extension is intended to provide both homologous and first heterologous booster data to complement previous positive Phase 1/2 booster results. The data are not intended for the initial regulatory approval process which the Company expects to finalize in the coming weeks. The trial ex
- Zacks
Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant
Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.
- Globe Newswire
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
Preliminary laboratory studies demonstrate that three doses of Valneva’s inactivated COVID-19 vaccine candidate VLA2001 induced neutralization of the Omicron variant (B.1.1.529 lineage) 100% of tested serum samples presented neutralizing antibodies against the ancestral virus and Delta variant, and 87% against the Omicron variant Saint Herblain (France), January 19, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced results from an initial laborat
